For example, LPS administration at 30 days post-TBI exacerbated cognitive impairment and induced depression-like behavior, both of which were associated with microglial reactivation and an exaggerated production of pro-inflammatory cytokines IL1-β and TNFα [45,46]. Here, IL1B is linked to depressive symptom measurement.